The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arjan Lalchandani, Promoter and Managing Director of Dr Lalchandani Labs Ltd, sold 76,000 equity shares through open market between June 10 and June 18, 2025. This represents a 1.75% reduction in his stake. His holding declined from 16,22,851 shares (37.45%) to 15,46,851 shares (35.70%) of the company's equity capital. The total equity share capital of the company remained at Rs. 4,33,30,680. The disclosure was filed under SEBI's Takeover Regulations to report the change in shareholding.
This is a promoter offloading shares in the open market, which retail investors may view as a mild negative signal regarding insider confidence, though the sale size is relatively small and the promoter remains the largest shareholder with over a third of the company.